Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,354,259
+$7,834,604 QoQ
Shares Held
59,095
+22.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#215
of 1,742 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$11,635,680
PutShares
24,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS holds $65,699,213 across 42 Biotechnology names. VRTX ranks #1 (44.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
59,095 | $29,354,259 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
109,905 | $9,556,239 | |
| 3 | EXEL |
Exelixis, Inc.
|
121,041 | $6,585,840 | |
| 4 | MRNA |
Moderna, Inc.
|
66,370 | $4,647,891 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,599 | $4,114,740 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
124,716 | $2,222,439 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
8,467 | $1,585,699 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
7,776 | $953,182 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,354,259 | 59,095 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,519,655 | 48,192 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $27,300,432 | 60,218 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,673,221 | 29,806 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,783,837 | 30,961 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,635,680 | 24,000 | Put | Sole | 2025-07-18 | |
| 2025-03-31 | $26,875,511 | 55,434 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $9,206,527 | 22,862 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,080,993 | 36,727 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,779,295 | 44,332 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,659,130 | 44,638 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $21,120,032 | 51,906 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $63,000,751 | 181,172 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $32,195,190 | 91,487 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,513,725 | 17,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,662,876 | 78,478 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $6,741,938 | 23,285 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,162,965 | 32,517 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,382,097 | 5,296 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,484,890 | 20,423 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,933,534 | 187,075 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $12,895,763 | 60,011 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,655,252 | 57,778 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,512,062 | 20,256 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,694,258 | 23,059 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,270,756 | 9,543 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||